• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解共晶和盐在水溶液中溶解度的差异。

Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.

机构信息

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109-1065.

Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109-1065.

出版信息

J Pharm Sci. 2018 Jan;107(1):113-120. doi: 10.1016/j.xphs.2017.10.033. Epub 2017 Oct 31.

DOI:10.1016/j.xphs.2017.10.033
PMID:29097226
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5774673/
Abstract

This work challenges the popular notion that pharmaceutical salts are more soluble than cocrystals. There are cocrystals that are more soluble than salt forms of a drug and vice-versa. It all depends on the interplay between the chemistry of both the solid and solution phases. Aqueous solubility, pH, and supersaturation index (SA = S/S or S/S) of cocrystals and salts of a basic drug, lamotrigine (LTG), were determined, and mathematical models that predict the influence of cocrystal/salt K and K were derived. K and SA followed the order LTG-nicotinamide cocrystal (18) > LTG-HCl salt (12) > LTG-saccharin salt (5) > LTG-methylparaben cocrystal (1) > LTG-phenobarbital cocrystal (0.2). The values in parenthesis represent SA under nonionizing conditions. Cocrystal/salt solubility and thermodynamic stability are determined by pH and will drastically change with a single unit change in pH. pH values ranged from 5.0 (saccharin salt) to 6.4 (methylparaben cocrystal) to 9.0 (phenobarbital cocrystal). Cocrystal/salt pH dependence on pK and pK shows that cocrystals and salts exhibit different behavior. Solubility and pH are as important as supersaturation index in assessing the stability and risks associated with conversions of supersaturating forms.

摘要

这项工作挑战了一个普遍的观点,即药物盐比共晶更易溶。有些共晶比药物的盐形式更易溶解,反之亦然。这完全取决于固相与溶液相之间的化学相互作用。测定了一种碱性药物拉莫三嗪(LTG)的共晶和盐的水溶解度、pH 值和过饱和度指数(SA=S/S 或 S/S),并推导出了预测共晶/盐 K 和 K 影响的数学模型。K 和 SA 遵循以下顺序:LTG-烟酰胺共晶(18)>LTG-HCl 盐(12)>LTG-糖精盐(5)>LTG-对羟基苯甲酸甲酯共晶(1)>LTG-苯巴比妥共晶(0.2)。括号中的值表示非电离条件下的 SA。共晶/盐的溶解度和热力学稳定性由 pH 值决定,pH 值的微小变化会导致其发生剧烈变化。pH 值范围从 5.0(糖精盐)到 6.4(对羟基苯甲酸甲酯共晶)到 9.0(苯巴比妥共晶)。共晶/盐对 pK 和 pK 的 pH 值依赖性表明,共晶和盐表现出不同的行为。在评估过饱和形式的稳定性和相关风险时,溶解度和 pH 值与过饱和度指数一样重要。

相似文献

1
Understanding the Differences Between Cocrystal and Salt Aqueous Solubilities.理解共晶和盐在水溶液中溶解度的差异。
J Pharm Sci. 2018 Jan;107(1):113-120. doi: 10.1016/j.xphs.2017.10.033. Epub 2017 Oct 31.
2
pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.在水介质中,依托 pH 值的变化,吲哚美辛-糖精和卡马西平-糖精共晶的溶解度。
Mol Pharm. 2012 Sep 4;9(9):2605-12. doi: 10.1021/mp300189b. Epub 2012 Aug 23.
3
The role of pH and dose/solubility ratio on cocrystal dissolution, drug supersaturation and precipitation.pH值和剂量/溶解度比在共晶溶解、药物过饱和及沉淀方面的作用。
Eur J Pharm Sci. 2020 Sep 1;152:105422. doi: 10.1016/j.ejps.2020.105422. Epub 2020 Jun 10.
4
Cocrystal Solubility Advantage Diagrams as a Means to Control Dissolution, Supersaturation, and Precipitation.共晶溶解度优势图作为控制溶解、过饱和和沉淀的手段。
Mol Pharm. 2019 Sep 3;16(9):3887-3895. doi: 10.1021/acs.molpharmaceut.9b00501. Epub 2019 Jul 31.
5
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.共晶以促进超过5规则的难溶性化合物的递送。
Adv Drug Deliv Rev. 2016 Jun 1;101:143-166. doi: 10.1016/j.addr.2016.04.022. Epub 2016 Apr 29.
6
Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.使用药物盐和共晶来解决溶解度差的问题。
Int J Pharm. 2013 Aug 30;453(1):88-100. doi: 10.1016/j.ijpharm.2012.11.028. Epub 2012 Nov 24.
7
Disproportionation of Pharmaceutical Salts: pH and Phase-Solubility/pH Variance.药物盐的歧化作用:pH 值和相溶解度/pH 值变化。
Mol Pharm. 2021 Jul 5;18(7):2724-2743. doi: 10.1021/acs.molpharmaceut.1c00258. Epub 2021 Jun 18.
8
Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.共晶减轻高pH值对碱性药物溶解度和溶出度的负面影响。
Cryst Growth Des. 2018 Mar 7;18(3):1358-1366. doi: 10.1021/acs.cgd.7b01206. Epub 2018 Feb 14.
9
Mechanistic Basis of Cocrystal Dissolution Advantage.共晶溶解优势的机制基础。
J Pharm Sci. 2018 Jan;107(1):380-389. doi: 10.1016/j.xphs.2017.09.014. Epub 2017 Oct 6.
10
Cocrystal Solubilization in Biorelevant Media and its Prediction from Drug Solubilization.共晶在生物相关介质中的溶解及其从药物溶解情况的预测
J Pharm Sci. 2015 Dec;104(12):4153-4163. doi: 10.1002/jps.24640. Epub 2015 Sep 21.

引用本文的文献

1
Novel Gastroprotective and Thermostable Cocrystal of Dimethyl Fumarate: Its Preparation, Characterization, and and Evaluation.新型富马酸二甲酯胃保护和热稳定共晶体:其制备、表征及评价
ACS Omega. 2023 Jul 11;8(29):26218-26230. doi: 10.1021/acsomega.3c02463. eCollection 2023 Jul 25.
2
Investigation of possible solubility and dissolution advantages of cocrystals, I: Aqueous solubility and dissolution rates of ketoconazole and its cocrystals as functions of pH.共晶体潜在溶解性和溶出优势的研究,I:酮康唑及其共晶体的水溶解度和溶出速率与pH的关系
ADMET DMPK. 2019 Apr 5;7(2):106-130. doi: 10.5599/admet.661. eCollection 2019.
3
Obtaining Cocrystals by Reaction Crystallization Method: Pharmaceutical Applications.通过反应结晶法制备共晶体:药物应用
Pharmaceutics. 2021 Jun 17;13(6):898. doi: 10.3390/pharmaceutics13060898.
4
Multicomponent crystalline solid forms of aripiprazole produced via hot melt extrusion techniques: An exploratory study.通过热熔挤出技术制备的阿立哌唑多组分晶体固体形式:一项探索性研究。
J Drug Deliv Sci Technol. 2021 Jun;63. doi: 10.1016/j.jddst.2021.102529. Epub 2021 Apr 20.
5
Co-crystals, Salts or Mixtures of Both? The Case of Tenofovir Alafenamide Fumarates.共晶体、盐类还是两者的混合物?替诺福韦艾拉酚胺富马酸盐的情况
Pharmaceutics. 2020 Apr 10;12(4):342. doi: 10.3390/pharmaceutics12040342.
6
Organic Salts of -Coumaric Acid and -Ferulic Acid with Aminopicolines.- 香豆酸和阿魏酸与氨基吡啶盐的有机盐。
Molecules. 2020 Feb 10;25(3):751. doi: 10.3390/molecules25030751.
7
Dissolution Advantage of Nitazoxanide Cocrystals in the Presence of Cellulosic Polymers.硝唑尼特共晶体在纤维素聚合物存在下的溶出优势。
Pharmaceutics. 2019 Dec 25;12(1):23. doi: 10.3390/pharmaceutics12010023.

本文引用的文献

1
Multidrug Cocrystal of Anticonvulsants: Influence of Strong Intermolecular Interactions on Physiochemical Properties.抗惊厥药的多药共晶:强分子间相互作用对物理化学性质的影响。
Cryst Growth Des. 2017 Oct 4;17(10):5012-5016. doi: 10.1021/acs.cgd.7b00741. Epub 2017 Sep 8.
2
Cocrystals Mitigate Negative Effects of High pH on Solubility and Dissolution of a Basic Drug.共晶减轻高pH值对碱性药物溶解度和溶出度的负面影响。
Cryst Growth Des. 2018 Mar 7;18(3):1358-1366. doi: 10.1021/acs.cgd.7b01206. Epub 2018 Feb 14.
3
Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.固态中的盐歧化反应:溶解度和抗衡离子挥发性的作用。
Mol Pharm. 2016 Dec 5;13(12):4141-4151. doi: 10.1021/acs.molpharmaceut.6b00745. Epub 2016 Nov 2.
4
Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5.共晶以促进超过5规则的难溶性化合物的递送。
Adv Drug Deliv Rev. 2016 Jun 1;101:143-166. doi: 10.1016/j.addr.2016.04.022. Epub 2016 Apr 29.
5
How cocrystals of weakly basic drugs and acidic coformers might modulate solubility and stability.弱碱性药物与酸性共形成物的共晶体如何调节溶解度和稳定性。
Chem Commun (Camb). 2016 Apr 30;52(34):5832-5. doi: 10.1039/c6cc00898d. Epub 2016 Apr 4.
6
Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.使用药物盐和共晶来解决溶解度差的问题。
Int J Pharm. 2013 Aug 30;453(1):88-100. doi: 10.1016/j.ijpharm.2012.11.028. Epub 2012 Nov 24.
7
pH-dependent solubility of indomethacin-saccharin and carbamazepine-saccharin cocrystals in aqueous media.在水介质中,依托 pH 值的变化,吲哚美辛-糖精和卡马西平-糖精共晶的溶解度。
Mol Pharm. 2012 Sep 4;9(9):2605-12. doi: 10.1021/mp300189b. Epub 2012 Aug 23.
8
Engineering cocrystal solubility, stability, and pH(max) by micellar solubilization.通过胶束增溶作用工程共晶溶解度、稳定性和 pH(max)。
J Pharm Sci. 2011 Dec;100(12):5219-34. doi: 10.1002/jps.22725. Epub 2011 Sep 9.
9
Rapid throughput screening of apparent KSP values for weakly basic drugs using 96-well format.使用96孔板形式对弱碱性药物的表观KSP值进行快速通量筛选。
J Pharm Sci. 2008 Jun;97(6):2080-90. doi: 10.1002/jps.21149.
10
Solubility of sparingly-soluble ionizable drugs.微溶性可电离药物的溶解度
Adv Drug Deliv Rev. 2007 Jul 30;59(7):568-90. doi: 10.1016/j.addr.2007.05.008. Epub 2007 May 29.